Pentobarbital - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for pentobarbital and what is the scope of patent protection?
Pentobarbital
is the generic ingredient in four branded drugs marketed by Sciegen Pharms Inc, Epic Pharma Llc, Lannett, Vitarine, Whiteworth Town Plsn, Anabolic, Elkins Sinn, Everylife, Halsey, Ivax Sub Teva Pharms, Parke Davis, Perrigo, Purepac Pharm, Valeant Pharm Intl, Watson Labs, Wyeth Ayerst, Rising, Bpi Labs, Hikma, Sagent Pharms Inc, and Nexgen Pharma Inc, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for pentobarbital.
Summary for pentobarbital
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 21 |
| NDAs: | 28 |
| Drug Master File Entries: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Clinical Trials: | 9 |
| Patent Applications: | 6,691 |
| Drug Prices: | Drug price trends for pentobarbital |
| DailyMed Link: | pentobarbital at DailyMed |
Recent Clinical Trials for pentobarbital
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sohag University | Phase 2/Phase 3 |
| Assiut University | N/A |
| Children's Hospital Medical Center, Cincinnati | Phase 1 |
Medical Subject Heading (MeSH) Categories for pentobarbital
Anatomical Therapeutic Chemical (ATC) Classes for pentobarbital
US Patents and Regulatory Information for pentobarbital
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Everylife | SODIUM PENTOBARBITAL | pentobarbital sodium | CAPSULE;ORAL | 083259-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciegen Pharms Inc | NEMBUTAL | pentobarbital sodium | SUPPOSITORY;RECTAL | 083247-003 | Jan 25, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciegen Pharms Inc | NEMBUTAL | pentobarbital sodium | SUPPOSITORY;RECTAL | 083247-002 | Jan 25, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sciegen Pharms Inc | NEMBUTAL | pentobarbital sodium | SUPPOSITORY;RECTAL | 083247-001 | Jan 25, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
